Clinical case series of nine patients with tuberculousmeningitis in the Clinical Centre of Vojvodina, Novi Sad, AP Vojvodina, Serbia 2001-2010

Doder, Radoslava; Čanak, Grozdana; Mikić, Sandra Stefan; Sević, Siniša; Potkonjak, Aleksandar; Doder, Dragan; Vračar, Vuk
August 2014
Medicinski Glasnik;Aug2014, Vol. 11 Issue 2, p312
Academic Journal
Aim To determine immediate risk factors of developing tuberculous meningitis, to assess the practical importance of clinical signs and findings in the cerebrospinal fluid (CSF) when opting for the specific therapy, and to predict the outcome of disease in relation to the beginning of treatment. Methods A retrospective clinical case series of nine patients with tuberculous meningitis who were treated from April 2001 until November 2010 at the Department of Infectious Diseases in Novi Sad, Serbia was presented. Data of patients' medical records and presentation of clinical and laboratory features, neuroradiological-findings and outcome were used. Results The factors of immediate risk/predisposition for the development of tuberculous meningitis were found in two (22.2%) patients. The duration of symptoms prior to admission was 9 days on average (from 3 to 20 days). The most frequent symptoms on admission were headache and fever in eight (88.9%) patients, whereas two patients (22.2%) were presented with stiff neck and photophobia. Consciousness was preserved in six patients (66.7%), two patients were somnolent and one was in coma. Two (22.2%) patients had concurrent pulmonary tuberculosis. Neuroradiological signs of the disease were present in two patients. Conclusion The duration of symptoms before admission, clinical examination and CSF analysis can be helpful in identifying patients who are at high risk of developing tuberculous meningitis.


Related Articles

  • Treatment Outcomes in Tuberculosis Patients with Diabetes: A Polytomous Analysis Using Brazilian Surveillance System. Reis-Santos, Bárbara; Gomes, Teresa; Locatelli, Rodrigo; de Oliveira, Elizabete R.; Sanchez, Mauro N.; Horta, Bernardo L.; Riley, Lee W.; Maciel, Ethel L. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: The impact of non-communicable diseases on tuberculosis incidence has received significant attention. It has been suggested that the risk of tuberculosis is higher among subjects with diabetes and these subjects also has poor TB treatment outcomes.This study was aimed at assessing...

  • Increased Risk of Active Tuberculosis following Acute Kidney Injury: A Nationwide, Population-Based Study. Wu, Vin-Cent; Wang, Chen-Yi; Shiao, Chih-Chung; Chang, Chia-Hsui; Huang, Hui-Yu; Huang, Tao-Min; Lai, Chun-Fu; Lin, Meng-Chun; Ko, Wen-Je; Wu, Kwan-Dun; Yu, Chong-Jen; Shu, Chin-Chung; Lee, Chih-Hsin; Wang, Jann-Yuan // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: Profound alterations in immune responses associated with uremia and exacerbated by dialysis increase the risk of active tuberculosis (TB). Evidence of the long-term risk and outcome of active TB after acute kidney injury (AKI) is limited. Methods: This population-based-cohort study...

  • Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis. Alffenaar, J. W. C.; van Altena, R.; Bökkerink, H. J.; Luijckx, G. J.; van Soolingen, D.; Aarnoutse, R. E.; van der Werf, T. S. // Clinical Infectious Diseases;10/1/2009, Vol. 49 Issue 7, p1080 

    Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF time concentration curves for 4 patients with tuberculous meningitis. The geometric mean ratio of the areas under the curve for CSF to plasma were 0.82 (range, 0.70-0.94) at 400 mg once per day and...

  • Detection of Antibody to Mycobacterium tuberculosis Protein Antigens in the Cerebrospinal Fluid of Patients with Tuberculous Meningitis. Chandramuki, Akepati; Lyashchenko, Konstantin; Kumari, Haradara Bahubali Veena; Khanna, Neelam; Brusasca, PierNatale; Gourie-Devi, Mandavalli; Satischandra, Parthasarathy; Shankar, Sursarla Krishna; Ravi, Vasanthapuram; Alcabes, Philip; Kanaujia, Ganga Vishnu; Gennaro, Maria Laura // Journal of Infectious Diseases;9/1/2002, Vol. 186 Issue 5, p678 

    Antibodies against Mycobacterium tuberculosis antigens were detected by enzyme-linked immunosorbent assay in cerebrospinal fluid (CSF) samples obtained from 442 patients with tuberculous meningitis (TBM) and 102 control patients. Antibodies were found in the CSF of 87% of patients with clinical...

  • The Association between Blood-Cerebrospinal Fluid Barrier Dysfunction and the Therapeutic Effect in Tuberculous Meningitis Patients. Tang, Jiangtao; An, Yunfei; Liao, Yun; Li, Yi; Li, Lixin; Wang, Lanlan // European Neurology;May2014, Vol. 71 Issue 5/6, p331 

    Objective: To explore the correlation of blood-cerebrospinal fluid (CSF) barrier (BCB) dysfunction with the therapeutic effect of antitubercular agents and their resistance, hoping to provide theoretical evidence for improvement of the therapeutic effect. Methods: Albumin in CSF and serum was...

  • Tuberculous meningitis in Denmark: a review of 50 cases. Christensen, Anne-Sophie H.; Andersen, Åse B.; Thomsen, Vibeke Ø.; Andersen, Peter H.; Johansen, Isik S. // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p47 

    Background: Tuberculous meningitis is the most severe manifestation of extrapulmonary tuberculosis with a high mortality rate and a high rate of sequelae among survivors. The aim of this study is to assess the current epidemiology, clinical features, diagnostic procedures, treatment and outcome...


    Background and aim. The Republic of Moldova reports the highest incidence of tuberculosis and the lowest treatment success rate among European region countries. In most of the patients the antituberculosis treatment failure is correlated with social risk factors (low socio-economical state,...

  • Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa. Moyo, Sizulu; Cox, Helen S.; Hughes, Jennifer; Daniels, Johnny; Synman, Leigh; De Azevedo, Virginia; Shroufi, Amir; Cox, Vivian; van Cutsem, Gilles // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: A community based drug resistant tuberculosis (DR-TB) program has been incrementally implemented in Khayelitsha, a high HIV and TB burden community in South Africa. We investigated loss from treatment (LFT), and post treatment outcomes of DR-TB patients in this setting. Methodology:...

  • Cytokine Profiles at Admission Can Be Related to Outcome in AIDS Patients with Cryptococcal Meningitis. Mora, Delio José; Fortunato, Laila Rigolin; Andrade-Silva, Leonardo Eurípedes; Ferreira-Paim, Kennio; Rocha, Ivonete Helena; Vasconcelos, Rakel Rocha; Silva-Teixeira, David Nascimento; Nascentes, Gabriel Antonio Nogueira; Silva-Vergara, Mario León // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Cryptococcal meningitis (CM) remains as common life-threatening AIDS-defining illness mainly in resource-limited settings. Previous reports suggested that baseline cytokine profiles can be associated to fungal burden and clinical outcome. This study aimed to evaluate the baseline cytokine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics